Johnson & Johnson Common Stock · Transaction Sep 8, 2026 · Filed Oct 5, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · JNJ
+0.20% · +$0.5000 · Vol Not reported
Pre-market · updated 04:02:42 ET
Johnson & Johnson
Pharmaceuticals
$249.11
Follow $JNJ
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $JNJ by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredTue Oct 13 · last completed session · Pre-market · regular session opens 9:30 ET · JNJ
MethodologyJNJ
Johnson & Johnson
Tue Oct 13 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
66/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Tue Oct 13 · last completed session · Pre-market · regular session opens 9:30 ET
AI Analysis
SovereignWhy is JNJ moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Johnson & Johnson
PHARMACEUTICAL PREPARATIONSListed since
1944
Employees
141K
Country
US
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$248.61
Last session
Day high
$248.61
Last session
Day low
$248.61
Last session
Previous close
$248.61
52W high
$278.43
-10.53% from high
52W low
$186.00
68% of range
Market cap
$599.1B
P/E
28.58×
EPS
$8.62
Beta
-0.52
Shares out
2.4B
Avg volume
6.9M
VWAP
$248.61
Last session
Price history computed in-house
1W
-3.61%
1M
-6.46%
3M
-0.34%
1Y
+30.53%
YTD
+20.37%
SMA 50 $265.37 · below
SMA 200 $243.41 · above
52W position 68%
JNJ overview
SEC industry peers
JNJ peers
Related filings and maps
Public disclosures
Congress activity in JNJ
78 filers · 185 buys · 138 sells (3 labeled S (partial)) · Dec 30, 2013 to Sep 8, 2026 · House 294 / Senate 29
All available history · Latest 5 of 323 lines · Read Oct 14, 2026, 8:11 AM UTC
Official filing ↗
Johnson & Johnson Common Stock · Transaction Aug 27, 2026 · Filed Sep 12, 2026 · $1,001 to $15,000
Johnson & Johnson Common Stock · Transaction Aug 20, 2026 · Filed Sep 11, 2026 · $1,001 to $15,000
Johnson & Johnson Common Stock · Transaction Jul 30, 2026 · Filed Aug 14, 2026 · $1,001 to $15,000
Johnson & Johnson Common Stock · Transaction Jun 29, 2026 · Filed Jul 15, 2026 · $1,001 to $15,000
Federal contracts
JNJ contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for JNJ in this window.
Lobbying spend
JNJ lobbying filings, year to date.
Registered lobbying filings matched to Johnson & Johnson.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for JNJ in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for JNJ.